Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prevalence and predictors of resistant hypertension in high-risk overweight and obese patients: A cross-sectional study based on the 2017 ACC/AHA guidelines.
Haddadin F, Sud K, Munoz Estrella A, Moctezuma S, Wu L, Berookhim J, Lucas CH, Patel D, Argulian E. Haddadin F, et al. Among authors: lucas ch. J Clin Hypertens (Greenwich). 2019 Oct;21(10):1507-1515. doi: 10.1111/jch.13666. Epub 2019 Aug 26. J Clin Hypertens (Greenwich). 2019. PMID: 31448866 Free PMC article.
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.
Lucas CG, Al-Adli NN, Young JS, Gupta R, Morshed RA, Wu J, Ravindranathan A, Shai A, Oberheim Bush NA, Taylor JW, de Groot J, Villanueva-Meyer JE, Pekmezci M, Perry A, Bollen AW, Theodosopoulos PV, Aghi MK, Chang EF, Hervey-Jumper SL, Raleigh DR, Molinaro AM, Costello JF, Diaz AA, Clarke JL, Butowski NA, Phillips JJ, Chang SM, Berger MS, Solomon DA. Lucas CG, et al. Neuro Oncol. 2024 Nov 19:noae214. doi: 10.1093/neuonc/noae214. Online ahead of print. Neuro Oncol. 2024. PMID: 39560080
Implications of molecular classifications in glioma surgery.
Kalluri AL, Lee JH, Lucas CG, Rincon-Torroella J, Bettegowda C. Kalluri AL, et al. J Neurooncol. 2024 Nov 12. doi: 10.1007/s11060-024-04883-0. Online ahead of print. J Neurooncol. 2024. PMID: 39532825 Review.
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis type 1 (NF1).
Lucas CG, Gross AM, Romo CG, Dehner CA, Lazar AJ, Miettinen M, Pekmezci M, Quezado M, Rodriguez FJ, Stemmer-Rachamimov A, Viskochil D, Perry A; Symposium on Atypical Neurofibroma: State of the Science Members. Lucas CG, et al. Neuro Oncol. 2024 Nov 6:noae235. doi: 10.1093/neuonc/noae235. Online ahead of print. Neuro Oncol. 2024. PMID: 39500722
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.
Chang M, Sherief M, Ioannou M, Chinnasamy V, Chen L, Frost M, Mattson-Hoss M, Sarnoff H, Kamson DO, Holdhoff M, Mukherjee D, Bettegowda C, Rincon-Torroella J, Croog V, Huang P, Rodriguez FJ, Lucas CG, Schreck KC. Chang M, et al. Acta Neuropathol Commun. 2024 Oct 29;12(1):172. doi: 10.1186/s40478-024-01875-z. Acta Neuropathol Commun. 2024. PMID: 39472976 Free PMC article.
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ.
Rincon-Torroella J, Rakovec M, Kalluri AL, Jiang K, Weber-Levine C, Parker M, Raj D, Materi J, Sepehri S, Ferres A, Schreck KC, Aldecoa I, Lucas CG, Sair HI, Redmond KJ, Holdhoff M, Weingart J, Brem H, Sánchez JJG, Ye X, Bettegowda C. Rincon-Torroella J, et al. J Neurooncol. 2024 Oct 9. doi: 10.1007/s11060-024-04829-6. Online ahead of print. J Neurooncol. 2024. PMID: 39382617
93 results